Cucurbitacins - a promising target for cancer therapy. 2013

Abdullah A Alghasham
College of Medicine, Qassim University, Kingdom of Saudi Arabia.

During the last decades a large number of cucurbitacins have been isolated from various plant species belonging to other plant families than Cucurbitaceae. Although the roots and the fruits of plant belong to these Cucurbitaceae species are very bitter, they have been used as folk medicines in some countries because of their wide spectrum of pharmacological activities such as anti-inflammation and anticancer effects. In the last ten years, cucurbitacins had been shown to inhibit proliferation and induced apoptosis utilizing a long array of in vitro and in vivo cancer cell models. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription (STAT), cyclooxygenase-2, etc. This review aimed at elucidating the natural sources of some cucurbitacin compounds, their chemical structure and derivatives, physical properties, biological activities and mechanism by which they reduce the proliferation human cancer cells. This widens our armaments against a devastating disease that we are failing to face.

UI MeSH Term Description Entries

Related Publications

Abdullah A Alghasham
January 2014, Current cancer drug targets,
Abdullah A Alghasham
October 2019, Journal of cancer research and clinical oncology,
Abdullah A Alghasham
August 2010, Yao xue xue bao = Acta pharmaceutica Sinica,
Abdullah A Alghasham
November 2013, Expert opinion on therapeutic targets,
Abdullah A Alghasham
February 2021, Molecular cancer,
Abdullah A Alghasham
January 2014, Advances in experimental medicine and biology,
Abdullah A Alghasham
January 2021, Oxidative medicine and cellular longevity,
Abdullah A Alghasham
July 2020, Histology and histopathology,
Abdullah A Alghasham
March 2014, Drug discovery today,
Abdullah A Alghasham
January 2022, International journal of medical sciences,
Copied contents to your clipboard!